Metabolomic Profiles in Jamaican Children With and Without Autism Spectrum Disorder

Area of Science:

• Neuroscience
• Metabolomics
• Biochemistry

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with poorly understood metabolic links.
• Metabolic perturbations may bridge genetic and environmental factors in ASD etiology.
• Identifying specific metabolite alterations can aid in biomarker discovery for ASD.

Purpose of the Study:

• To conduct a metabolomic case-control study to identify significant metabolite profile alterations in children with ASD compared to typically developing (TD) controls.
• To discover potential metabolic biomarkers for ASD.
• To explore the role of metabolites in ASD etiology.

Main Methods:

• A case-control study involving 200 children with ASD and 200 TD controls (ages 2-8) from Jamaica.
• Targeted metabolomic profiling of plasma samples using liquid chromatography-mass spectrometry.
• Statistical analysis adjusting for age, sex, socioeconomic status, and birth parish.

Main Results:

• Four metabolites showed significant differences between children with ASD and TD controls.
• Three identified metabolites were fatty acids: myristoleic acid, eicosatetraenoic acid, and octadecenoic acid.
• The amino acid sarcosine was significantly associated with ASD.

Conclusions:

• Metabolic profiles differ between children with ASD and TD controls.
• Specific fatty acids and sarcosine may serve as potential biomarkers for ASD.
• Findings suggest avenues for developing targeted metabolic interventions for ASD.